Bristol Myers makes late play for COVID-19 antibody space, picking up 2 early-phase molecules from Rockefeller

Bristol Myers makes late play for COVID-19 antibody space, picking up 2 early-phase molecules from Rockefeller

Source: 
Fierce Biotech
snippet: 

Bristol Myers Squibb has secured global rights to a pair of anti-SARS-CoV-2 antibodies discovered by The Rockefeller University. The antibodies entered phase 1 development last month, putting them well behind similar therapies from companies including Eli Lilly and Regeneron.